학술논문
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
Document Type
Artikel
Author
Source
EBioMedicine. 66:103327
Subject
Language
English
English
English
ISSN
2352-3964